IQVIA MedTech Perspectives
Welcome to the first edition of IQVIA MedTech Perspectives, our latest thinking on various key issues shaping the MedTech industry across the world.
Regulations and Reimbursement for Software as a Medical Device in Europe Part 3 Whitepaper
In this newly released third part in the series, we cover both the current reimbursement pathways for SaMD in Europe (by looking into the pioneering countries with systematic pathways for reimbursement of digital health solutions), and explore the expected development in the reimbursement of digital healthcare in the coming years. Download part 1 here and part 2 here.
The Impact of GLP-1 Agonists on the MedTech Sector: Articulating a continued value proposition for devices Blogosition for devices Blog
MedTech stocks continue to feel pressure from glucagon-like peptide-1 (GLP-1) drugs for obesity, based primarily on speculation. As the noise around GLP-1s and their potential impact on the MedTech sector intensifies, IQVIA MedTech discuss the importance of having the right data and analytics in place to cut through the generalizations - allowing you to reveal the complete picture for your business.
Understanding In Vitro Diagnostic (IVD) Risk-Based Classification in EU and US Insight Brief.
There are many challenges faced by IVD manufacturers as they navigate the evolving global regulatory landscapes. As manufacturers strive to meet new requirements in transitioning from the In Vitro Diagnostic Directive (IVDD) to IVDR, we provide critical insight to help you navigate the complexity of IVD regulations. Download our latest Insight Brief now.
Key Learnings from the MedTech Conference 2023 Insight Brief
In October the medical device community gathered in Anaheim for the MedTech Conference; an annual event convened by Advamed industry association. Over 3000 business leaders, regulators, physicians, and patients discussed current healthcare challenges and opportunities for innovation. In this insight brief, you will read the key learnings from the IQVIA MedTech team.
Advancing Digital Health Innovation Using Real World Evidence Webinar
The digital health landscape is evolving rapidly with an increasing spotlight on the use of RWE across the digital health total product lifecycle. Regulators, payers, and other key stakeholders are increasingly looking to RWE to guide decision-making from code to commercialization. Watch back this webinar as we explore the use of RWE by regulators and payers, and how emerging digital health technologies are being used for evidence generation.
If you have any questions, or want to get in touch to discuss potential future topics you would like the IQVIA MedTech team to tackle, please feel free to email us: mailto:meddevice@us.imshealth.com
If you wish to receive this via email in future, please subscribe here, ensure the “Opt In” box is ticked.